ANTICANCER RES 2020 10.21873/anticanres.14271
Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology
Park1, S; Cho, EY; Oh, YL; Park, YH; Kim, HS

BREAST CANCER RES TR 2019 10.1007/s10549-019-05192-1
miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway
Lee1, J; Kim, HE; Song, YS; Cho, EY; Lee, A

J BREAST CANC 2019 10.4048/jbc.2019.22.e17
Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
Jang1, Y; Cho, EY; Cho, SY

J CELL MOL MED 2019 10.1111/jcmm.14194
Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non- small cell lung cancer cells
Lee1, BB; Kim, Y; Kim, D; Cho, EY; Han, J; Kim, HK; Shim, YM; Kim, DH

PLoS One 2019 10.1371/journal.pone.0212309
Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment
Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

ANTICANCER RES 2019 10.21873/anticanres.13121
Clinicopathological and Molecular Characteristics of Mammary Adenoid Cystic Carcinoma With Adipocytic Differentiation With Emphasis on the Identification of a Novel BRAF Mutation
Bae1, GE; Yoon, N; Cho, EY; Kim, HS; Cho, SY

J BREAST CANC 2018 10.4048/jbc.2018.21.e48
PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis
Seo1, Y; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Cho, SY; Cho, EY

BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort
Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

EXP MOL PATHOL 2018 10.1016/j.yexmp.2018.03.006
Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers
Chin1, SF; Santonja, A; Grzelak, M; Ahn, S; Sammut, SJ; Clifford, H; Rueda, OM; Pugh, M; Goldgraben, MA; Bardwell, HA; Cho, EY; Provenzano, E; Rojo, F; Alba, E; Caldas, C

Ultrasound Q 2017 10.1097/RUQ.0000000000000307
Lymphoma Involving Skin and Subcutaneous Fat of the Breast: Two Cases
Kwon1, M; Ko, EY; Han, BK; Ko, YH; Cho, EY; Cho, SY; Kim, SY

J BREAST CANC 2017 10.4048/jbc.2017.20.3.286
NanoString nCounter (R) Approach in Breast Cancer: A Comparative Analysis with Quantitative Real-Time Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry
Hyeon1, J; Cho, SY; Hong, ME; Kang, SY; Doe, I; Im, YH; Cho, EY

ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652
Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy
Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746
Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy
Yoon N1, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY

J Thorac Oncol. 2016 Dec;11(12):2193-2201. doi: 10.1016/j.jtho.2016.07.021. Epub 2016 Aug 4.
Overexpression of beta-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy
Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim HK3, Kim DH4.

Genet Med. 2016 Dec;18(12):1250-1257. doi: 10.1038/gim.2016.39. Epub 2016 Apr 28.
Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants
Park KS11, Cho EY2, Nam SJ3, Ki CS4, Kim JW4.

Breast Cancer Res Treat. 2016 Dec;160(3):475-489. doi: 10.1007/s10549-016-4008-4. Epub 2016 Oct 11.
Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems
Choi M11, Park YH2, Ahn JS2, Im YH2, Nam SJ3, Cho SY4, Cho EY5.

Cancer Res Treat. 2016 Oct;48(4):1338-1350. Epub 2016 Feb 18.
Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
Kim JY11, Park K2, Jung HH3, Lee E2, Cho EY4, Lee KH5, Bae SY6, Lee SK6, Kim SW6, Lee JE6, Nam SJ6, Ahn JS1, Im YH1,3, Park YH1,3.

J Breast Cancer. 2016 Sep;19(3):330-333. Epub 2016 Sep 23.
Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
Seong M11, Ko EY1, Han BK1, Cho SY2, Cho EY2, Lee SK3, Lee JE3.

Sci Rep. 2016 Jun 24;6:28623. doi: 10.1038/srep28623.
Gene Expression Profiling of Breast Cancer Brain Metastasis
Lee JY11, Park K2, Lee E2, Ahn T2, Jung HH3, Lim SH1, Hong M4, Do IG4, Cho EY4, Kim DH5, Kim JY1, Ahn JS1, Im YH1,2, Park YH1,3.

Genes Chromosomes Cancer. 2016 Jun;55(6):495-504. doi: 10.1002/gcc.22351. Epub 2016 Mar 3.
Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade
Yoon N11, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.

Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11.
Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes
Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Acta Radiol. 2016 May;57(5):521-8. doi: 10.1177/0284185115590287. Epub 2015 Jun 12.
Shear-wave elastography in invasive ductal carcinoma: correlation between quantitative maximum elasticity value and detailed pathological findings
Cho EY11, Ko ES2, Han BK3, Kim RB4, Cho S1, Choi JS3, Hahn SY3.

Int J Exp Pathol. 2016 Apr;97(2):170-7. doi: 10.1111/iep.12187. Epub 2016 Jun 9.
Expression of FOXM1 and related proteins in breast cancer molecular subtypes
Lee JJ11, Lee HJ2, Son BH3, Kim SB4, Ahn JH4, Ahn SD5, Cho EY6, Gong G2.

Medicine (Baltimore). 2016 Jan;95(3):e2453. doi: 10.1097/MD.0000000000002453.
Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis Correlations With Detailed Pathological Findings
Ko ES11, Kim JH, Lim Y, Han BK, Cho EY, Nam SJ.

PLoS One. 2015 Dec 2;10(12):e0144046. doi: 10.1371/journal.pone.0144046. eCollection 2015.
Initial Experience with a Wireless Ultrasound-Guided Vacuum-Assisted Breast Biopsy Device
Choi ER11, Han BK1, Ko ES1, Ko EY1, Choi JS1, Cho EY2, Nam SJ3.

Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18.
Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments
Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Clin Breast Cancer. 2015 Oct;15(5):353-61.e1-2. doi: 10.1016/j.clbc.2015.01.008. Epub 2015 Feb 7.
Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06)
Yu JI11, Choi DH2, Huh SJ1, Cho EY3, Kim K4, Chie EK4, Ha SW4, Park IA5, Ahn SJ6, Lee JS7, Shin KH8, Kwon Y8, Kim YB9, Suh CO9, Koo JS10, Kim JH11, Jeong BG12, Kim IA13, Lee JH14, Park W1.

Int J Cancer. 2015 Apr 15;136(8):1976-84. doi: 10.1002/ijc.29233. Epub 2014 Dec 24.
A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery
Park YH11, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.

Radiology. 2015 Apr;275(1):235-44. doi: 10.1148/radiol.14141129. Epub 2014 Dec 11.
Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer
Hyun SH11, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.

Clin Epigenetics. 2015 Mar 19;7(1):32. doi: 10.1186/s13148-015-0066-4. eCollection 2015.
RAR beta 2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim DH4.

Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7.
Invasive Paget disease of the breast: 20 years of experience at a single institution
Lee HW11, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.

APMIS. 2014 Sep;122(9):755-60. doi: 10.1111/apm.12215. Epub 2013 Dec 20.
Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH
Yoon N11, Do IG, Cho EY.

Oncology. 2014;86(5-6):279-88. doi: 10.1159/000362281. Epub 2014 Jun 4.
Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers
Park YH11, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.

Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24.
Aberrant DNA methylation of integrin alpha 4 in human breast cancer
Do SI11, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.

J Breast Cancer. 2014 Jun;17(2):113-20. doi: 10.4048/jbc.2014.17.2.113. Epub 2014 Jun 27.
Positive Expression of Insulin-Like Growth Factor-1 Receptor Is Associated with a Positive Hormone Receptor Status and a Favorable Prognosis in Breast Cancer
Shin SJ11, Gong G1, Lee HJ1, Kang J2, Bae YK3, Lee A4, Cho EY5, Lee JS6, Suh KS7, Lee DW8, Jung WH9.

Radiology. 2014 Apr;271(1):30-7. doi: 10.1148/radiol.13131073. Epub 2013 Nov 21.
Apparent Diffusion Coefficient in Estrogen Receptor-Positive Invasive Ductal Breast Carcinoma: Correlations with Tumor-Stroma Ratio
Ko ES11, Han BK, Kim RB, Cho EY, Ahn S, Nam SJ, Ko EY, Shin JH, Hahn SY.

J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28.
Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ
Lee JH11, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.

Korean J Radiol. 2014 Jan-Feb;15(1):20-8. doi: 10.3348/kjr.2014.15.1.20. Epub 2014 Jan 8.
Breast Metastases from Extramammary Malignancies: Typical and Atypical Ultrasound Features
Mun SH11, Ko EY2, Han BK2, Shin JH2, Kim SJ3, Cho EY4.

Mod Pathol. 2013 May;26(5):677-84. doi: 10.1038/modpathol.2012.205. Epub 2012 Dec 14.
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas
Cho EY11, Park K, Do I, Cho J, Kim J, Lee J, Kim S, Kim KM, Sohn TS, Kang WK, Kim S.

Korean J Pathol. 2013 Apr;47(2):172-6. doi: 10.4132/KoreanJPathol.2013.47.2.172. Epub 2013 Apr 24.
Congenital Peribronchial Myofibroblastic Tumor: A Case Study and Literature Review
Kim Y11, Park HY, Cho J, Han J, Cho EY.

Clin Cancer Res. 2013 Mar 1;19(5):1204-12. doi: 10.1158/1078-0432.CCR-12-2848. Epub 2013 Jan 14.
Association of RASSF1A and p63 with Poor Recurrence-Free Survival in Node-Negative Stage I-II Non-Small Cell Lung Cancer
Ko E11, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.

Ann Surg Oncol. 2013 Mar;20(3):1005-12. doi: 10.1245/s10434-012-2727-2. Epub 2012 Nov 1.
Synergistic Effect of Bcl-2 and Cyclin A2 on Adverse Recurrence-Free Survival in Stage I Non-small Cell Lung Cancer
Ko E11, Kim Y, Cho EY, Han J, Shim YM, Park J, Kim DH.

Tumour Biol. 2013 Feb;34(1):445-53. doi: 10.1007/s13277-012-0569-y. Epub 2012 Nov 14.
Expression of TWIST1, Snail, Slug, and NF-kappa B and methylation of the TWIST1 promoter in mammary phyllodes tumor
Do SI11, Kim JY, Kang SY, Lee JJ, Lee JE, Nam SJ, Cho EY.

Acta Oncol. 2013 Jan;52(1):73-81. doi: 10.3109/0284186X.2012.731520. Epub 2012 Oct 17.
Prognostic impact of FOXP3 expression in triple-negative breast cancer
Lee S11, Cho EY, Park YH, Ahn JS, Im YH.

Korean J Pathol. 2012 Dec;46(6):554-61. doi: 10.4132/KoreanJPathol.2012.46.6.554. Epub 2012 Dec 26.
Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR
Lee JJ11, Ko E, Cho J, Park HY, Lee JE, Nam SJ, Kim DH, Cho EY.

J Breast Cancer. 2012 Dec;15(4):381-7. doi: 10.4048/jbc.2012.15.4.381. Epub 2012 Dec 31.
HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer
Bae YK11, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW, Jung WH; Breast Pathology Study Group of Korean Society of Pathologists.

Am J Surg Pathol. 2012 Dec;36(12):1817-25. doi: 10.1097/PAS.0b013e318267b012.
Hormone Receptor Expression in Invasive Breast Cancer Among Korean Women and Comparison of 3 Antiestrogen Receptor Antibodies A Multi-institutional Retrospective Study Using Tissue Microarrays
Bae YK11, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW.

Tumour Biol. 2012 Oct;33(5):1573-80. doi: 10.1007/s13277-012-0411-6. Epub 2012 May 13.
The prognostic significance of tumor-associated stroma in invasive breast carcinoma
Ahn S11, Cho J, Sung J, Lee JE, Nam SJ, Kim KM, Cho EY.

Lung Cancer. 2012 Aug;77(2):401-6. doi: 10.1016/j.lungcan.2012.03.027. Epub 2012 Apr 24.
Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer
Ko E11, Kim Y, Park SE, Cho EY, Han J, Shim YM, Park J, Kim DH.

Invest Radiol. 2012 Jun;47(6):368-75. doi: 10.1097/RLI.0b013e31824baff3.
Hepatic Fat Quantification A Prospective Comparison of Magnetic Resonance Spectroscopy and Analysis Methods for Chemical-Shift Gradient Echo Magnetic Resonance Imaging With Histologic Assessment as the Reference Standard
Kang BK11, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG.

Pathology. 2012 Apr;44(3):216-20. doi: 10.1097/PAT.0b013e3283513e8b.
Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas
Cho EY11, Srivastava A, Park K, Kim J, Lee MH, Do I, Lee J, Kim KM, Sohn TS, Kang WK, Kim S.

Cancer?Chemother Pharmacol.?2011 Sep;68(3):753-61. doi: 10.1007/s00280-010-1548-x. Epub 2010 Dec 18.
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
Cho EY11,?Chang MH,?Choi YL,?Lee JE,?Nam SJ,?Yang JH,?Park YH,?Ahn JS,?Im YH.

Breast Cancer Res. 2010;12(6):R100. doi: 10.1186/bcr2783. Epub 2010 Nov 23.
Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer
Ko E11, Park SE, Cho EY, Kim Y, Hwang JA, Lee YS, Nam SJ, Bang S, Park J, Kim DH.

Comparative Study of Metaplastic Breast Carcinoma and Triple-Negative Breast Carcinoma Using Histologic and Immunohistochemical Analyses
J Surg Oncol. 2010 Sep 1;102(3):225-9. doi: 10.1002/jso.21607.
The Prediction of Lymph Node Metastasis in Ductal Carcinoma In Situ With Microinvasion by Assessing Lymphangiogenesis
Lee SK11, Cho EY, Kim WW, Kim SH, Hur SM, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Cancer Res. 2010 Jul 15;70(14):5674-8. doi: 10.1158/0008-5472.CAN-08-2660. Epub 2010 Jun 15.
PIK3CA Mutations in In situ and Invasive Breast Carcinomas
Miron A11, Varadi M, Carrasco D, Li H, Luongo L, Kim HJ, Park SY, Cho EY, Lewis G, Kehoe S, Iglehart JD, Dillon D, Allred DC, Macconaill L, Gelman R, Polyak K.

No items found.
Intracystic Papillary Carcinoma in the Male Breast
J Surg Oncol. 2010 Feb 1;101(2):137-40. doi: 10.1002/jso.21453.
Characteristics of Metastasis in the Breast From Extramammary Malignancies
Lee SK11, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

No items found.
Increased Expression of Autophagy Protein Beclin1 and LC3 in High-grade Hepatocellular Carcinoma and Metastatic Carcinoma
J Korean Med Sci. 2008 Dec;23(6):1053-61. doi: 10.3346/jkms.2008.23.6.1053. Epub 2008 Dec 24.
Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study
Cho EY11, Han JJ, Choi YL, Kim KM, Oh YL.

Int J Cancer. 2008 Nov 1;123(9):2073-9. doi: 10.1002/ijc.23598.
CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha 4 is associated with recurrence of early stage esophageal squamous cell carcinoma
Lee EJ11, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH.

J Korean Med Sci. 2008 Apr;23(2):185-92. doi: 10.3346/jkms.2008.23.2.185.
The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: Incidence of disease entities by age groups
Cho EY11, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH.

Pathol Int. 2008 Jan;58(1):17-25.
Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: Immunohistochemistry and chromogenic in situ hybridization
Cho EY11, Choi YL, Han JJ, Kim KM, Oh YL.

AJNR Am J Neuroradiol. 2007 Aug;28(7):1242-8.
Spinal epidural hemangiomas: Various types of MR imaging features with histopathologic correlation
Lee JW11, Cho EY, Hong SH, Chung HW, Kim JH, Chang KH, Choi JY, Yeom JS, Kang HS.

APMIS. 2007 Jun;115(6):713-8.
AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas
Cho EY11, Kim KM, Park CK, Kim JJ, Sohn TS, Kim DW.

Cytopathology. 2007 Feb;18(1):20-7.
Fine needle aspiration cytology of solitary fibrous tumours of the pleura
Cho EY11, Han JJ, Han J, Oh YL.

J Korean Med Sci. 2006 Jun;21(3):425-9.
Polycystin-1 expression in fetal, adult and autosomal dominant polycystic kidney
Chae SW11, Cho EY, Park MS, Lee KB, Kim H, Kim U.

Eur J Cancer. 2006 May;42(7):972-80. Epub 2006 Mar 27.
Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma
Lee EJ11, Lee BB, Kim JW, Shim YM, Hoseok I, Han J, Cho EY, Park J, Kim DH.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1000-6.
Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms
Cho EY11, Choi YL, Chae SW, Sohn JH, Ahn GH.

Radiology. 2006 Apr;239(1):105-12. Epub 2006 Feb 16.
Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment
Park SH11, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY.

Pathol Int. 2006 Feb;56(2):62-70.
Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms
Cho EY11, Choi Y, Chae SW, Sohn JH, Ahn GH.

Hum Pathol. 2002 Jul;33(7):732-40.
Focal follicular features in tonsillar diffuse large B-cell lymphomas: Follicular lymphoma with diffuse areas or follicular colonization
Ree HJ11, Kikuchi M, Lee SS, Ohshima K, Yang WI, Ko YH, Cho EY, Rhee JC.

J Korean Med Sci. 2002 Feb;17(1):137-40.
Trilateral retinoblastoma: A case report
Cho EY11, Suh YL, Shin HJ.

Hum Pathol. 2001 Sep;32(9):954-62.
Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: Significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma
Ree HJ11, Yang WI, Kim CW, Huh J, Lee SS, Cho EY, Ko YH, Charney D.

Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):222-8.
Immunoexpression of inhibin alpha-subunit in adrenal neoplasms
Cho EY11, Ahn GH.

Acta Cytol. 2001 May-Jun;45(3):353-9.
Fine needle aspiration cytology of sclerosing adenosis of the breast
Cho EY11, Oh YL.